Hemoglobinopathies Market Growth 2022-2027, Share, Trends

The latest research study “Hemoglobinopathies Market Growth: Global Industry Trends, Share, Size, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global hemoglobinopathies market reached a value of US$ 8.36 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 14.8 Billion by 2027 exhibiting a CAGR of 9.50% during 2022-2027.

Hemoglobinopathies represent a group of genetic blood disorders that cause structural and production abnormalities in hemoglobin molecules. They are detected by genetic testing, high-performance liquid chromatography, routine red blood cell count, hemoglobin isoelectric focusing, hemoglobin electrophoresis test, etc. Some of the common variants of hemoglobinopathies include sickle cell, thalassemia, beta-thalassemia, etc. Antibiotics, ACE inhibitors, blood transfusions, hydroxyurea, stem-cell transplantation, and analgesic are widely utilized as hemoglobinopathies treatment solutions.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/hemoglobinopathies-market/requestsample

Hemoglobinopathies Market Trends and Drivers:

The rising prevalence of numerous medical conditions, including sickle cell disease (SCD) and thalassemia, is one of the key factors driving the hemoglobinopathies market. In line with this, the expanding geriatric population, who are more susceptible to several chronic ailments, including anemia, is further catalyzing the market growth.

Moreover, the inflating adoption of gene therapy for the treatment of hemoglobinopathies at affordable costs is acting as another significant growth-inducing factor. In line with this, the launch of various favorable policies by government bodies across countries to introduce novel therapies and the growing healthcare sector are also augmenting the global market.

Additionally, the increasing investments in R&D activities to develop CRISPR-Cas9 technology by adding, editing, removing, altering, and modifying the DNA are anticipated to fuel the hemoglobinopathies market over the forecasted period.

Hemoglobinopathies Market Report Scope
Report Coverage Details
Market size value in 2021 US$ 8.36 Billion
Market forecast in 2027 US$ 14.8 Billion
Growth Rate CAGR of 9.50% from 2022 to 2027
Base year for estimation 2021
Historical data 2016-2021
Forecast period 2022-2027

Global Hemoglobinopathies Market 2022-2027 Analysis and Segmentation:

 Competitive Landscape:

 The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Bio-Rad Laboratories Inc., bluebird bio Inc., Bristol-Myers Squibb Company, Danaher Corporation, Emmaus Life Sciences Inc., Gamida-Cell Ltd., Global Blood Therapeutics Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Prolong Pharmaceuticals LLC, Sangamo Therapeutics Inc. and Sysmex Corporation.

The report has segmented the market on the basis of region, type, treatment, test type and end user.

Breakup by Type:

  • Thalassemia
    • Alpha Thalassemia
    • Beta Thalassemia
  • Sickle Cell Disease
  • Others

Breakup by Treatment:

  • Blood Transfusion
  • Stem-cell Transplantation
  • Analgesics
  • Antibiotics
  • ACE Inhibitors
  • Hydroxyurea
  • Others

Market Breakup by Test Type:

  • Red Blood Cell (RBC) Count
  • Genetic Testing
  • High Performance Liquid Chromatography (HPLC)
  • Hemoglobin Isoelectric Focusing (Hb IEF)
  • Hemoglobin Electrophoresis (Hb ELP)

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

 Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/hemoglobinopathies-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Read Also : Macular Degeneration Treatment Market Growth 2022-2027


About Maria James

Check Also

Phone Repair Store

How to Know Which Phone Repair Store is The Best

Due to the need for accurate precision, extensive knowledge, and expertise, cell phone repair is …

Leave a Reply

Your email address will not be published. Required fields are marked *